Phase I study of vemurafenib in children with recurrent or progressive BRAFV600E mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002) is a research paper published in Oncotarget (2020). On theSindex it has a DataRank of 3.0. It has been cited 89 times, with 83 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.675
From this paper's citation signal
Citation Network Contribution
2.3
From 67 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 83 citers.
NCATS NIH HHS
Grant: UL1 TR001863
NCI NIH HHS
Grant: P50 CA097257
NCATS NIH HHS
Grant: KL2 TR001862
National Institutes of Health
Grant: 5P50CA097257-12
BRAIN TUMOR SPORT GRANT
FWCI
3.28
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals